Glenmark to Pay $30 Million to Resolve Drug Price-Fixing Charges by DOJ
Glenmark Pharmaceutical has entered into an agreement with the United States Department of Justice, Antitrust Division (DOJ) to resolve charges alleging its involvement with Teva...